STOCK TITAN

AIP Form 144 Notice: 19,060 Shares Planned Sale Worth $200,130

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arteris, Inc. reported a Form 144 notice showing an intended sale of 19,060 shares of its common stock by a holder using Morgan Stanley Smith Barney LLC as broker, with an aggregate market value of $200,130.00. The filing states the shares were acquired as Restricted Stock Units on 09/03/2024 and the planned approximate sale date is 10/02/2025 on NASDAQ. The issuer has 42,649,917 shares outstanding per the filing. The notice also lists multiple recent sales by the same person under a 10b5-1 plan and direct sales between 07/03/2025 and 09/09/2025, totaling tens of thousands of shares and several hundred thousand dollars in gross proceeds.

Positive

  • Securities were acquired as Restricted Stock Units, indicating standard equity compensation rather than insider purchases
  • Planned sale is modest relative to outstanding shares (19,060 vs 42,649,917 outstanding)

Negative

  • Recent selling activity under a 10b5-1 plan and direct sales includes larger totals (e.g., 34,400 shares on 08/05/2025), which may reflect notable insider disposition
  • Form 144 records multiple sales over the past months with aggregate gross proceeds in the hundreds of thousands of dollars

Insights

TL;DR: An insider intends to sell 19,060 RSU-derived shares worth $200,130; recent 10b5-1 and direct sales are listed.

The Form 144 shows the securities to be sold were acquired as Restricted Stock Units on 09/03/2024, indicating the holder is disposing of recently vested equity rather than long-held stock.

The filing records several sales executed under a 10b5-1 plan and one direct sale between 07/03/2025 and 09/09/2025, with individual gross proceeds reported (for example, $466,763.28 on 08/05/2025).

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Arteris (AIP) Form 144 report?

The Form 144 reports an intended sale of 19,060 common shares valued at $200,130.00, to be sold approximately on 10/02/2025 on NASDAQ.

How were the shares being sold acquired for AIP?

The shares were acquired as Restricted Stock Units on 09/03/2024 and the filing lists the acquisition date as 09/03/2024.

Who is the broker handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York.

Does the filing show prior sales by the same person?

Yes. The filing lists multiple prior sales under a 10b5-1 plan and one direct sale between 07/03/2025 and 09/09/2025, with gross proceeds reported for each transaction.

How many AIP shares are outstanding per the filing?

The filing reports 42,649,917 shares outstanding.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

705.93M
31.36M
30.11%
47.91%
3.85%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL